-
Loading metrics
Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
- Saskia Maletzke,
- Azam Salimi,
- Margherita Vieri,
- Kema Marlen Schroeder,
- Mirle Schemionek,
- Behzad Kharabi Masouleh,
- Tim H. Brümmendorf,
- Steffen Koschmieder,
- Iris Appelmann
x
- Published: October 4, 2022
- https://doi.org/10.1371/journal.pone.0268352